Literature DB >> 14754980

Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study.

Kar Hui Ng1, Daniel Chong, Chin Khoon Wong, Hian Tat Ong, Chien Yee Lee, Bee Wah Lee, Lynette Pei-Chi Shek.   

Abstract

OBJECTIVE: Allergic rhinitis is common and on the rise. Antihistamines are the mainstay of treatment and are the most commonly prescribed drugs in Singapore. Treatment-related sedation and its effect on cognition are a major concern. First- and second-generation antihistamines show varying degrees of sedation, but to date, objective studies in children are lacking. The objective of this study was to assess the sedating effect of cetirizine (second-generation antihistamine) and chlorpheniramine (first-generation antihistamine) compared with placebo using an objective neurophysiological test.
METHODS: This was a prospective, double-blind, placebo-controlled, randomized, single-dose, 3-way crossover study. Twenty-four children aged 7 to 14 years with allergic rhinitis completed the study. All children were randomly allocated to medication sequences and received 3 different drugs on 3 different days, at least 1 week apart. The P300 event-related potential was used as an objective test of sedation. Subjective assessment was by a visual analog scale.
RESULTS: Chlorpheniramine and cetirizine increased P300 latency when compared with baseline. No significant increase was obtained with placebo. The significant increase in P300 latency was not accompanied by significant change in subjective somnolence as measured by the visual analog scale.
CONCLUSION: We have shown that cetirizine has sedative properties in children. The lack of correlation between P300 latency and the visual analog scale indicates that sedation induced by these drugs may not be subjectively noted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14754980     DOI: 10.1542/peds.113.2.e116

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration.

Authors:  Xiaomei I Liu; Paul Schuette; Gilbert J Burckart; Dionna J Green; Julie La; Janelle M Burnham; Natella Rakhmanina; Adelaide Robb; Shiew Mei Huang; John N van den Anker
Journal:  J Pediatr       Date:  2019-01-21       Impact factor: 4.406

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Effects of sedative and nonsedative antihistamines on prefrontal activity during verbal fluency task in young children: a near-infrared spectroscopy (NIRS) study.

Authors:  Takeo Tsujii; Sayako Masuda; Eriko Yamamoto; Takayuki Ohira; Takekazu Akiyama; Takao Takahashi; Shigeru Watanabe
Journal:  Psychopharmacology (Berl)       Date:  2009-08-25       Impact factor: 4.530

5.  Sensing and responding to allergic response cytokines through a genetically encoded circuit.

Authors:  Hélène Chassin; Barbara Geering; Lina Schukur; David Ausländer; Brian Lang; Martin Fussenegger
Journal:  Nat Commun       Date:  2017-10-24       Impact factor: 14.919

6.  Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis.

Authors:  Pengxiang Zhou; Qiong Jia; Zhenhuan Wang; Rongsheng Zhao; Wei Zhou
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.